Publicação
Impact of digital transformation in pharmaceutical industry: A study of factors of disruptive technology adoption
| Resumo: | The digital transformation phenomenon is already a reality for most of the sectors and organizations of different sizes. The transformation powered by the adoption and use of disruptive technologies such as 5G network, Cloud Technology (CT), Internet of Things (IoT), Artificial Intelligence (AI) & Machine Learning (ML), Advanced Robotics, augmented (AR) and Virtual Reality (VR) and Big Data (BD) led to changes in the organization processes, ways of working, product, and service conception. The disruptive technologies, when correctly employed have the potential to improve productivity, reduce costs, create new offerings, mitigate, and reduce risk, creating and unlocking value to companies. It is a consensus among scholars and practitioners that the COVID 19 outbreak totally changed and accelerated the need for the adoption of digital technologies, not simply by surfing the trend, but for the survival of the organizations. The Pharmaceutical and Healthcare industries are among the companies that lately have been employing disruptive technologies to become more efficient and innovative, looking to improve internal processes, reducing cost, driving innovation, mitigating risks, developing of new offerings of products and services. Using a Design Science Research and survey with experienced professionals, it was found that the most relevant factors to the adoption of disruptive technology within pharmaceutical and healthcare are “Leadership sponsorship”, “Clear digital transformation long term vision/strategy”, “Willingness to experiment”. Considering the adoption and use of disruptive technologies drives significant changes in the organizations, the objective of this thesis is to seek understanding on the factors and its relevance to organization under the digital transformation process, with the intention to shed light on the enablers that should be taken into account by practitioners in this situation. The work developed in this dissertation and the findings could help practitioners to better understand which factors should be considered during a digital transformation process. For scholars, this dissertation promotes a discussion of areas urging for more research and studies in order to better understand the digital transformation within the pharmaceutical and healthcare sectors and the impacts on value creation for firms and patients. |
|---|---|
| Autores principais: | Almeida, Victor Miranda de |
| Assunto: | Digital Transformation Pharmaceutical Industry Digitalization Value Creation SDG 3 - Good health and well-being SDG 4 - Educação de qualidade SDG 8 - Decent work and economic growth SDG 9 - Industry, innovation and infrastructure SDG 10 - Reduced inequalities SDG 11 - Sustainable cities and communities SDG 17 - Partnerships for the goals |
| Ano: | 2024 |
| País: | Portugal |
| Tipo de documento: | dissertação de mestrado |
| Tipo de acesso: | acesso embargado |
| Instituição associada: | Universidade Nova de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Institucional da UNL |
| Resumo: | The digital transformation phenomenon is already a reality for most of the sectors and organizations of different sizes. The transformation powered by the adoption and use of disruptive technologies such as 5G network, Cloud Technology (CT), Internet of Things (IoT), Artificial Intelligence (AI) & Machine Learning (ML), Advanced Robotics, augmented (AR) and Virtual Reality (VR) and Big Data (BD) led to changes in the organization processes, ways of working, product, and service conception. The disruptive technologies, when correctly employed have the potential to improve productivity, reduce costs, create new offerings, mitigate, and reduce risk, creating and unlocking value to companies. It is a consensus among scholars and practitioners that the COVID 19 outbreak totally changed and accelerated the need for the adoption of digital technologies, not simply by surfing the trend, but for the survival of the organizations. The Pharmaceutical and Healthcare industries are among the companies that lately have been employing disruptive technologies to become more efficient and innovative, looking to improve internal processes, reducing cost, driving innovation, mitigating risks, developing of new offerings of products and services. Using a Design Science Research and survey with experienced professionals, it was found that the most relevant factors to the adoption of disruptive technology within pharmaceutical and healthcare are “Leadership sponsorship”, “Clear digital transformation long term vision/strategy”, “Willingness to experiment”. Considering the adoption and use of disruptive technologies drives significant changes in the organizations, the objective of this thesis is to seek understanding on the factors and its relevance to organization under the digital transformation process, with the intention to shed light on the enablers that should be taken into account by practitioners in this situation. The work developed in this dissertation and the findings could help practitioners to better understand which factors should be considered during a digital transformation process. For scholars, this dissertation promotes a discussion of areas urging for more research and studies in order to better understand the digital transformation within the pharmaceutical and healthcare sectors and the impacts on value creation for firms and patients. |
|---|